[1] |
Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008, 21(3): 538-582.
|
[2] |
Lauretti L, D’Alessandris QG, Fantoni M, et al. First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant acinetobacter baumannii[J]. J Neurosurg, 2017, 127(2): 370-373.
|
[3] |
中国医师协会神经外科医师分会神经重症专家委员会,北京医学会神经外科学分会神经外科危重症学组.神经外科中枢神经系统感染诊治中国专家共识(2021版)[J].中华神经外科杂志, 2021, 37(1): 2-15.
|
[4] |
杨小锋,王浩.重视神经重症患者颅内感染的防治[J].中华创伤杂志, 2019, 35(1): 6-9.
|
[5] |
习慧明,徐英春,朱德妹,等. 2010年中国CHINET鲍曼不动杆菌耐药性监测[J].中国感染与化疗杂志, 2012, 12(2): 98-104.
|
[6] |
陈佰义,何礼贤,胡必杰,等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中华医学杂志, 2012, 92(2): 76-85.
|
[7] |
Piparsania S, Rajput N, Bhatambare G. Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii-case report and review of literature[J]. Turk J Pediatr, 2012, 54(5): 548-554.
|
[8] |
Karaiskos I, Galani L, Baziaka F, et al. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review[J]. Int J Antimicrob Agents, 2013, 41(6): 499-508.
|
[9] |
Harms JM, Bartels H, Schlünzen F, et al. Antibiotics acting on the translational machinery[J]. J Cell Sci, 2003, 116(Pt 8): 1391-1393.
|
[10] |
Hirata T, Nomura W, Imanishi M, et al. Effects of linking 15-zinc finger domains on DNA binding specificity and multiple DNA binding modes[J]. Bioorg Med Chem Lett, 2005, 15(9): 2197-2201.
|
[11] |
梅升辉,朱乐亭,杨莉,等.替加环素治疗颅内耐药菌感染的研究进展[J].中国药房, 2016, 27(14): 2005-2008.
|
[12] |
Pallotto C, Fiorio M, D’Avolio A, et al. Cerebrospinal fluid penetration of tigecycline[J]. Scand J Infect Dis, 2014, 46(1): 69-72.
|
[13] |
Sullins AK, Abdel-Rahman SM. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents[J]. Paediatr Drugs, 2013, 15(2): 93-117.
|
[14] |
Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis[J]. Clin Infect Dis, 2017, 64(6): e34-e65.
|
[15] |
Fang YQ, Zhan RC, Jia W, et al. A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii[J]. Medicine (Baltimore), 2017, 96(31): e7703.
|
[16] |
Deng ZW, Wang J, Qiu CF, et al. A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial acinetobacter baumannii infection[J]. Medicine (Baltimore), 2019, 98(15): e15139.
|
[17] |
焦永成,孔海波,刘爱军,等.替加环素鞘内注射治疗多重耐药鲍曼不动杆菌颅内感染[J].临床神经外科杂志, 2020, 17(1): 90-93.
|
[18] |
Wu Y, Chen K, Zhao J, et al. Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report[J]. J Chemother, 2018, 30(1): 49-52.
|
[19] |
梁舒瑶,王辰潇,刘维,等.替加环素超剂量使用与临床结局相关性的评价[J].中国临床药理学杂志, 2018, 34(3): 362-364.
|